Last reviewed · How we verify
Systemic sclerosis associated interstitial lung disease
Approved treatments
- Ofev · Boehringer Ingelheim
Ofev works by blocking enzymes that promote fibrosis and tumor growth. - OFEV® · Boehringer Ingelheim
- vargatef · ARCAGY/ GINECO GROUP
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Systemic sclerosis associated interstitial lung disease patent landscape — cliff calendar, originator estates, attackable patents
- Systemic sclerosis associated interstitial lung disease treatment landscape brief
- Systemic sclerosis associated interstitial lung disease treatment updates RSS
Frequently asked questions about Systemic sclerosis associated interstitial lung disease
What drugs treat Systemic sclerosis associated interstitial lung disease?
Tracked treatments include Ofev, OFEV®, vargatef.
What is the treatment for Systemic sclerosis associated interstitial lung disease?
Standard treatment for Systemic sclerosis associated interstitial lung disease includes Ofev, OFEV®, vargatef. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Systemic sclerosis associated interstitial lung disease patent cliff · Systemic sclerosis associated interstitial lung disease CI report
- Treatment: Ofev · Boehringer Ingelheim
- Treatment: OFEV® · Boehringer Ingelheim
- Treatment: vargatef · ARCAGY/ GINECO GROUP
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing